Trastuzumab Deruxtecan 100mg Injection — HER2-Targeted Antibody-Drug Conjugate for HER2-Positive and HER2-Low Breast Cancer, Gastric Cancer and HER2-Mutant NSCLC
Ribociclib 200mg Film-Coated Tablets — CDK4/6 Inhibitor for HR-Positive HER2-Negative Advanced and Metastatic Breast Cancer With Proven Overall Survival Benefit Across Pre/Perimenopausal and Postmenopausal Women